FDA granted emergency use authorization on April 25 to a rapid diagnostic for use in government laboratories to help detect the H7N9 variant of avian flu in U.S. citizens who have traveled to China.
The authorization, for Fremont, Calif.-based Arbor Vita Corp.’srapid H7N9 assay, is the third emergency authorization granted by FDA for a diagnostic targeting this strain since it was officially deemed...